Injective

Injective (INJ) is changing hands at $7.50, putting its market capitalization — price multiplied by circulating supply — at roughly $749.8 million. The token has dropped 9.6% in the past 24 hours and 6.6% over the last week, though it's still sitting on a 4.8% gain for the month. The Fear & Greed Index, a widely-used gauge of overall crypto sentiment, reads 28 (Fear), and its steady seven-day trend suggests this defensive mood is settling in rather than lifting anytime soon. Coin-specific red flags add to the pressure: zero recorded GitHub commits in the past four weeks and extreme ownership concentration, with the top 10 addresses holding 96.34% of tracked supply. On the brighter side, several smart-contract security checks came back clean, the project has a long history of code contributions, and a recent headline flagged an Injective exchange-traded fund (ETF) debuting on Nasdaq. Taken together, this investment research (MiFID II Del. Reg 2017/565 Art. 36) finds the negatives — weak sentiment, a tough macro backdrop, concentrated holdings, and stalled development — currently outweigh the positives.

Injective (INJ) is changing hands at $7.83 after a sharp 8.39% jump in the past 24 hours, though its weekly gain sits at a far more modest 1.53% and its 30-day gain at 4.22%. That gap matters: the rally looks like a one-session spike rather than a steady multiweek climb. Sentiment is a sticking point too. The Fear & Greed Index reads 34 — squarely in Fear territory — and has dropped 17 points over the past week, even after a small bounce from 26 the day before. On the project side, Injective's GitHub has logged zero code changes in four weeks, and wallet concentration is extreme: the 10 largest addresses hold 96.31% of the tracked balance. A clean security scan and two institutional-access announcements offer some reassurance, but neither one demonstrates real growth in network adoption. Taken together, this investment research (MiFID II Del. Reg 2017/565 Art. 36) points to a strained outlook over a weeks-to-months horizon — cautious sentiment, tighter macro conditions, and project-level red flags outweigh the recent price bounce.

Injective is changing hands at $7.33 after sliding 10.1% in 24 hours, 6.8% over the past week, and 4.4% over the last month. The two coin-specific figures that stand out most: 96.3% of tracked balances sit in just ten addresses, and GitHub shows zero commits over the past four weeks. The broader Fear & Greed Index reads 51 (Neutral), a slight tick up from 50 a week earlier — the market isn't panicking, but it isn't offering much lift either. Coverage of Injective's new AI-compute markets and recent meetings with US officials has been neutral rather than bullish, and none of it has translated into price strength. This investment research (MiFID II Del. Reg 2017/565 Art. 36) finds that while favorable smart-contract results and fresh use cases offer some support, heavy concentration, stalled development activity, and a harsher macro backdrop leave the overall setup strained.

Injective (INJ) is changing hands at $7.89, down 9.03% over the past 24 hours and 6.01% over the past week — though it's still up 1.43% on a 30-day view. This coin analysis flags one concentration issue right away: the top-10 address concentration measure sits at 96.3%, meaning a small cluster of wallets holds outsized sway over the token (note: addresses aren't necessarily the same as individual people or entities, since one holder can control multiple wallets). Developer activity has also gone quiet, with zero GitHub commits (recorded code changes) over the last four weeks. Meanwhile, the Fear & Greed Index reads 68 — labeled Greed — up five points in a week, pointing to stronger risk appetite across the broader market that INJ simply hasn't benefited from. On the brighter side, a security trust score of 70, a reported burn of more than 7.2 million INJ, and new Korean-won stablecoin plans offer some counterbalance. For investors weighing this coin forecast, the takeaway is that concentration risk, stalled development, and a tough macro backdrop currently outweigh the positive sentiment and ecosystem headlines.

Injective (INJ) is changing hands at $9.32 after climbing 9.9% in the past 24 hours, 11.1% over the last week, and 15.7% over the past month. The Fear & Greed Index now sits at 63 — in 'Greed' territory — up from 53 just a week ago, pointing to a broader appetite for risk across the market, though such fast-rising enthusiasm can also make gains harder to sustain. The backdrop looks constructive on the ecosystem side: a partnership with BDACS, a Korean won stablecoin settlement deal, growing tokenized-asset activity, and a proposed INJC staking ETF all feature in recent headlines. That said, two caution flags stand out — the ten largest wallet addresses hold 96.35% of the tokens measured, and GitHub shows zero code commits over the past four weeks. Taken together, this coin analysis suggests that improving price momentum and ecosystem buzz are being counterbalanced by concentrated ownership, a quiet development cycle, and a tougher macro climate of rising interest rates and inflation.